Stockscreener 앱 받기
23.58
2.57%
-0.57
Immunovant Inc 주식(IMVT)의 최신 뉴스
Oppenheimer Maintains Outperform Rating on Immunovant (IMVT) Following Q2 2026 Earnings - MSN
(IMVT) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com
12 Best Short Squeeze Stocks to Buy Right Now - Insider Monkey
Officer Geffner Files To Sell 50,000 Of Immunovant Inc [IMVT] - TradingView
Immunovant (IMVT): Assessing Valuation Following R&D Leadership Restructuring and CMO Departure - Sahm
JPMorgan Lowers PT on Immunovant (IMVT) to $33 From $37 - MSN
Have Insiders Sold Immunovant Shares Recently? - simplywall.st
Immunovant Restructures R&D Leadership with CMO Departure - The Globe and Mail
Immunovant COO Gloria sells $298k in shares By Investing.com - Investing.com Nigeria
Immunovant COO Gloria sells $298k in shares - Investing.com
Immunovant Insider Sold Shares Worth $298,237, According to a Recent SEC Filing - MarketScreener
Immunovant COO Gloria Melanie Sells Shares to Cover Tax Obligations - TradingView
[Form 4] Immunovant, Inc. Insider Trading Activity - Stock Titan
[8-K] Immunovant, Inc. Reports Material Event | IMVT SEC FilingForm 8-K - Stock Titan
Immunovant, Inc. Announces Cessation of Michael Geffner, M.D., M.B.A. as Chief Medical Officer, Effective November 21, 2025 - MarketScreener
How analysts rate Immunovant Inc. stock todayInsider Selling & Technical Entry and Exit Tips - newser.com
Will Immunovant Inc. stock outperform value stocksTrade Exit Summary & Weekly Breakout Watchlists - newser.com
Is Immunovant Inc. stock affected by interest rate hikesJuly 2025 Gainers & Stepwise Trade Signal Implementation - newser.com
Can swing trading help recover from Immunovant Inc. losses2025 Pullback Review & Accurate Intraday Trading Signals - newser.com
How Immunovant Inc. stock performs after earningsJuly 2025 Spike Watch & Community Consensus Trade Signals - newser.com
Responsive Playbooks and the IMVT Inflection - news.stocktradersdaily.com
Is Immunovant Inc. meeting your algorithmic filter criteriaPortfolio Value Summary & Safe Capital Growth Stock Tips - newser.com
Is Immunovant Inc. stock oversold or undervalued2025 Price Momentum & Weekly High Potential Alerts - newser.com
Key resistance and support levels for Immunovant Inc.Global Markets & Risk Adjusted Swing Trade Ideas - newser.com
Will Immunovant Inc. stock go up soonTrade Performance Summary & Free Low Drawdown Momentum Trade Ideas - newser.com
Sentiment analysis tools applied to Immunovant Inc.Weekly Stock Report & Low Risk High Win Rate Stock Picks - newser.com
Why Immunovant Inc. stock is popular among millennials2025 Technical Overview & Community Consensus Picks - newser.com
Why Immunovant Inc. stock is recommended by analystsWeekly Trade Analysis & Consistent Income Trade Ideas - newser.com
How institutional ownership impacts Immunovant Inc. stockMarket Activity Summary & Daily Profit Maximizing Trade Tips - newser.com
Immunovant, Inc. (NASDAQ:IMVT) Q2 2025 Earnings Call Transcript - Insider Monkey
Immunovant Inc Stock Analysis and ForecastStock Buyback Updates & Explosive Capital Growth Plans - earlytimes.in
Immunovant’s Earnings Call Highlights Clinical Success and Financial Strength - MSN
Immunovant's Q2 Loss Wider Than Expected, Pipeline in Focus - MSN
Immunovant stock rating reiterated by Oppenheimer, cites progress in autoimmune portfolio - Investing.com South Africa
Immunovant Bets Big On Autoimmune Drug Pipeline Progress - Finimize
Immunovant, Inc. (NASDAQ:IMVT) Q2 2026 Earnings Call Transcript - Insider Monkey
0.25%
자본화:
|
볼륨(24시간):